QIMR Berghofer
Rochelle DSouza is a postdoctoral researcher at QIMR Berghofer Medical Research Institute since September 2015, focusing on identifying novel drug targets in brain cancer to enhance patient survival. Previous positions include postdoctoral roles at the University of Sydney and the Garvan Institute of Medical Research, where Rochelle specialized in mass spectrometry-based proteomics related to diabetes. Educational background includes a PhD from the Max Planck Institute of Biochemistry and an MS in Biotechnology from Mysore University. Additional experience encompasses research and training roles, including a guest lecturer position at Mangalore University and research work on axon guidance and cancer studies.